June 8: Millions of unused Johnson & Johnson vaccines are set to expire by the end of June, and hospitals and health departments are struggling to figure out what to do with them.
June 9: A small study published in Nature showed the Johnson & Johnson vaccine was effective against several coronavirus variants.
June 10: The U.S. stopped sending new shipments of Johnson & Johnson’s vaccine to states in a move expected to help clear a backlog of unused doses that are set to expire by the end of June. The pause is expected to be temporary.
June 10: The FDA extended the shelf life of Johnson & Johnson’s vaccine from three months to 4.5 months.
June 11: The FDA ordered Johnson & Johnson to throw away 60 million doses of its COVID-19 vaccine because of possible contamination at Emergent BioSolutions’ manufacturing plant in Baltimore.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
